1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. UROGEN PHARMA LTD
UroGen Pharma Ltd
XNAS: URGN
29.68 -1.26 (-4.07%)
813.6K
XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for UroGen Pharma Ltd is on 19 May 2026 for the purpose of HC Wainwright 4(th) Annual BioConnect Investor Conference See details

UroGen Pharma Ltd - URGN - stock price prediction, stock price target, analyst ratings from 8 analysts

UroGen Pharma Ltd has a share price target of US$ 36, revenue growth forecast of 139.8%, and profit growth estimate of 71.0% for FY26, based on top 8 analyst calls.